These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27331588)

  • 1. Safety Profile of PrePex Male Circumcision Device and Client Satisfaction With Adolescent Males Aged 13-17 Years in Zimbabwe.
    Tshimanga M; Hatzold K; Mugurungi O; Mangwiro T; Ncube G; Xaba S; Chatikobo P; Gundidza P; Samkange C; Dhlamini R; Murwira M; Gwinji G
    J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S36-42. PubMed ID: 27331588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse event profile of a mature voluntary medical male circumcision programme performing PrePex and surgical procedures in Zimbabwe.
    Bochner AF; Feldacker C; Makunike B; Holec M; Murenje V; Stepaniak A; Xaba S; Balachandra S; Tshimanga M; Chitimbire V; Barnhart S
    J Int AIDS Soc; 2017 Feb; 19(1):21394. PubMed ID: 28362066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the PrePex device an alternative for surgical male circumcision in adolescents ages 13-17 years? Findings from routine service delivery during active surveillance in Zimbabwe.
    Mavhu W; Hatzold K; Madidi N; Maponga B; Dhlamini R; Munjoma M; Xaba S; Ncube G; Mugurungi O; Cowan FM
    PLoS One; 2019; 14(3):e0213399. PubMed ID: 30856228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of the PrePex Male Circumcision Device: Results From Pilot Implementation Studies in Mozambique, South Africa, and Zambia.
    Feldblum P; Martinson N; Bvulani B; Taruberekera N; Mahomed M; Chintu N; Milovanovic M; Hart C; Billy S; Necochea E; Samona A; Mhazo M; Bossemeyer D; Lai JJ; Lebinai L; Ashengo TA; Macaringue L; Veena V; Hatzold K
    J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S43-8. PubMed ID: 27331589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Acceptability of the PrePex Device When Used in Routine Male Circumcision Service Delivery During Active Surveillance in Zimbabwe.
    Mavhu W; Hatzold K; Ncube G; Xaba S; Madidi N; Keatinge J; Dhodho E; Samkange CA; Tshimanga M; Mangwiro T; Mugurungi O; Njeuhmeli E; Cowan FM
    J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S63-8. PubMed ID: 27331593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analysis of integrating the PrePex medical device into a voluntary medical male circumcision program in Zimbabwe.
    Njeuhmeli E; Kripke K; Hatzold K; Reed J; Edgil D; Jaramillo J; Castor D; Forsythe S; Xaba S; Mugurungi O
    PLoS One; 2014; 9(5):e82533. PubMed ID: 24801515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and acceptance of the PrePex device for non-surgical adult male circumcision in Rakai, Uganda. A non-randomized observational study.
    Kigozi G; Musoke R; Watya S; Kighoma N; Nkale J; Nakafeero M; Namuguzi D; Serwada D; Nalugoda F; Sewankambo N; Wawer MJ; Gray RH
    PLoS One; 2014; 9(8):e100008. PubMed ID: 25144194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Cost Analysis of Surgical and PrePex Device Male Circumcision in Zimbabwe and Mozambique.
    Schutte C; Tshimanga M; Mugurungi O; Come I; Necochea E; Mahomed M; Xaba S; Bossemeyer D; Ferreira T; Macaringue L; Chatikobo P; Gundididza P; Hatzold K
    J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S96-S100. PubMed ID: 27331599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase II Randomized Controlled Trial Comparing Safety, Procedure Time, and Cost of the PrePex™ Device to Forceps Guided Surgical Circumcision in Zimbabwe.
    Tshimanga M; Mangwiro T; Mugurungi O; Xaba S; Murwira M; Kasprzyk D; Montaño DE; Nyamukapa D; Tambashe B; Chatikobo P; Gundidza P; Gwinji G
    PLoS One; 2016; 11(5):e0156220. PubMed ID: 27227679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating Opportunities for Achieving Cost Efficiencies Through the Introduction of PrePex Device Male Circumcision in Adult VMMC Programs in Zambia and Zimbabwe.
    Vandament L; Chintu N; Yano N; Mugurungi O; Tambatamba B; Ncube G; Xaba S; Mpasela F; Muguza E; Mangono T; Madidi N; Samona A; Tagar E; Hatzold K
    J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S90-5. PubMed ID: 27331598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systems-based assessment of the PrePex device adverse events active surveillance system in Zimbabwe.
    Adamson PC; Tafuma TA; Davis SM; Xaba S; Herman-Roloff A
    PLoS One; 2017; 12(12):e0190055. PubMed ID: 29272320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piloting PrePex for Adult and Adolescent Male Circumcision in South Africa--Pain Is an Issue.
    Lebina L; Taruberekera N; Milovanovic M; Hatzold K; Mhazo M; Nhlapo C; Tshabangu N; Manentsa M; Kazangarare V; Makola M; Billy S; Martinson N
    PLoS One; 2015; 10(9):e0138755. PubMed ID: 26405786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of adverse events among voluntary medical male circumcision clients: Implications from routine service delivery in Zimbabwe.
    Feldacker C; Bochner AF; Murenje V; Makunike-Chikwinya B; Holec M; Xaba S; Balachandra S; Mandisarisa J; Sidile-Chitimbire V; Barnhart S; Tshimanga M
    PLoS One; 2018; 13(9):e0203292. PubMed ID: 30192816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PrePex circumcision surveillance: Adverse events and analgesia for device removal.
    Lebina L; Milovanovic M; Otwombe K; Abraham P; Manentsa M; Nzenze S; Martinson N
    PLoS One; 2018; 13(3):e0194271. PubMed ID: 29579082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-arm, open-label, prospective, cohort field study to assess the safety and efficacy of the PrePex device for scale-up of nonsurgical circumcision when performed by nurses in resource-limited settings for HIV prevention.
    Mutabazi V; Kaplan SA; Rwamasirabo E; Bitega JP; Ngeruka ML; Savio D; Karema C; Binagwaho A
    J Acquir Immune Defic Syndr; 2013 Jul; 63(3):315-22. PubMed ID: 23466648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, effectiveness and acceptability of the PrePex device for adult male circumcision in Kenya.
    Feldblum PJ; Odoyo-June E; Obiero W; Bailey RC; Combes S; Hart C; Jou Lai J; Fischer S; Cherutich P
    PLoS One; 2014; 9(5):e95357. PubMed ID: 24788898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events profile of PrePex a non-surgical device for adult male circumcision in a Ugandan urban setting.
    Galukande M; Duffy K; Bitega JP; Rackara S; Bbaale DS; Nakaggwa F; Nagaddya T; Wooding N; Dea M; Coutinho A
    PLoS One; 2014; 9(1):e86631. PubMed ID: 24489754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of the PrePex device in HIV-positive men: A single-arm study in Zimbabwe.
    Tshimanga M; Makunike-Chikwinya B; Mangwiro T; Tapiwa Gundidza P; Chatikobo P; Murenje V; Herman-Roloff A; Kilmarx PH; Holec M; Gwinji G; Mugurungi O; Murwira M; Xaba S; Barnhart S; Feldacker C
    PLoS One; 2017; 12(12):e0189146. PubMed ID: 29220392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected Complications Following Adult Medical Male Circumcision Using the PrePex Device.
    Odoyo-June E; Feldblum PJ; Fischer S; Bailey RC; Obiero W; Hart C; Veena V; Combes S; Cherutich P
    Urol Int; 2016; 96(2):188-93. PubMed ID: 26684654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the cost of adult voluntary medical male circumcision in a mixed (surgical and PrePex) site compared to a hypothetical PrePex-only site in South Africa.
    Kim HY; Lebina L; Milovanovic M; Taruberekera N; Dowdy DW; Martinson NA
    Glob Health Action; 2015; 8():29116. PubMed ID: 26679407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.